{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:12:19Z","timestamp":1748365939396,"version":"3.28.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ymgme.2024.108581","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T23:34:23Z","timestamp":1727566463000},"page":"108581","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategy"],"prefix":"10.1016","volume":"143","author":[{"given":"Camille","family":"Moreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Paquot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Soto","family":"Ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Fr\u00e9d\u00e9rique","family":"Dessein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Beghyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dries","family":"Dobbelaere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108581_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0099-5428(05)32002-8","article-title":"Niclosamide: comprehensive profile","volume":"32","author":"Al-Hadiya","year":"2005","journal-title":"Profil. Drug Substan. Excip. Relat. Methodol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108581_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1982","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2024.108581_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2012.03.058","article-title":"Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins","volume":"213","author":"Baarine","year":"2012","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108581_bb0020","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.biocel.2013.06.019","article-title":"Peroxisomes: the neuropathological consequences of peroxisomal dysfunction in the developing brain","volume":"45","author":"Barry","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"13","key":"10.1016\/j.ymgme.2024.108581_bb0025","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/ajmg.a.32298","article-title":"Peroxisomal acyl-CoA-oxidase deficiency: two new cases","volume":"146A","author":"Carrozzo","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2024.108581_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108581_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2020.02.021","article-title":"Loss or gain of function mutations in ACOX1 cause axonal loss via different mechanisms","volume":"106","author":"Chung","year":"2020","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108581_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.03.022","article-title":"Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation","volume":"35","author":"Chung","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2024.108581_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653101","article-title":"Neuron-oligodendrocyte interactions in the structure and integrity of axons","volume":"9","author":"Duncan","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108581_bb0050","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1210\/en.2012-1137","article-title":"The inflammatory response in acyl-CoA oxidase 1 deficiency (Pseudoneonatal Adrenoleukodystrophy)","volume":"153","author":"El Hajj","year":"2012","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108581_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/humu.20535","article-title":"Clinical, biochemical, and mutational spectrum of peroxisomal acyl\u2013coenzyme a oxidase deficiency","volume":"28","author":"Ferdinandusse","year":"2007","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.2009.176255","article-title":"Adult peroxisomal acyl-coenzyme a oxidase deficiency with cerebellar and brainstem atrophy","volume":"81","author":"Ferdinandusse","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108581_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp-2021-328045","article-title":"Diagnostic approach in adult-onset neurometabolic diseases","volume":"93","author":"Fern\u00e1ndez-Eulate","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108581_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.braindev.2005.10.010","article-title":"Aberrant peroxisome morphology in peroxisomal beta-oxidation enzyme deficiencies","volume":"28","author":"Funato","year":"2006","journal-title":"Brain and Development"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108581_bb0075","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddn066","article-title":"Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture","volume":"17","author":"Hein","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2024.108581_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108581_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","article-title":"Combined liquid chromatography\u2013tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings","volume":"89","author":"Hubbard","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108581_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2017.10.012","article-title":"Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy","volume":"122","author":"Huffnagel","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108581_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00690","article-title":"Comparison of the diagnostic performance of C26:0-Lysophosphatidylcholine and very long-chain fatty acids analysis for Peroxisomal disorders","volume":"8","author":"Jaspers","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.ymgme.2024.108581_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1004978","article-title":"The magic bullet: Niclosamide","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"issue":"04","key":"10.1016\/j.ymgme.2024.108581_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0036-1582140","article-title":"Clinical and biochemical pitfalls in the diagnosis of Peroxisomal disorders","volume":"47","author":"Klouwer","year":"2016","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108581_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10545-017-0064-0","article-title":"Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders","volume":"40","author":"Klouwer","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108581_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0031-1275729","article-title":"Contrast enhancement of brainstem tracts in Zellweger spectrum disorder: evidence of inflammatory demyelination","volume":"42","author":"Kulkarni","year":"2011","journal-title":"Neuropediatrics"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108581_bb0120","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpn.2016.02.007","article-title":"Early white matter involvement in an infant carrying a novel mutation in ACOX1","volume":"20","author":"Masson","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00346","article-title":"Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models","volume":"21","author":"Milani","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymgme.2024.108581_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129498","article-title":"SAR study of niclosamide derivatives for neuroprotective function in SH-SY5Y neuroblastoma","volume":"96","author":"Mito","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108581_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10545-016-9952-y","article-title":"A novel method for determining peroxisomal fatty acid \u03b2-oxidation","volume":"39","author":"Morita","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108581_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2017.09.006","article-title":"Quantitative neuroimaging in mucopolysaccharidoses clinical trials","volume":"122","author":"Nestrasil","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JRS-2008-0440","article-title":"A review of the safety of niclosamide, pyrantel, triclabendazole and oxamniquine","volume":"20","author":"Ofori-Adjei","year":"2008","journal-title":"Intern. J. Risk Safety Med."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108581_bb0155","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1248\/bpb.b20-00108","article-title":"Mitochondrial Uncouplers confer protection by activating AMP-activated protein kinase to inhibit Neuroinflammation following intracerebral hemorrhage","volume":"43","author":"Pan","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0160","first-page":"422","article-title":"A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo\u2013neonatal adrenoleukodystrophy)","volume":"42","author":"Poll-The","year":"1988","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108581_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","article-title":"Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy","volume":"59","author":"Powers","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108581_bb0170","first-page":"567","article-title":"A microglial cell model for acyl-CoA oxidase 1 deficiency","volume":"1864","author":"Raas","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108581_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2006-923943","article-title":"Pitfall in metabolic screening in a patient with fatal Peroxisomal \u03b2-oxidation defect","volume":"37","author":"Rosewich","year":"2006","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2011.11.195","article-title":"Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: Prospective newborn screening for X-linked adrenoleukodystrophy","volume":"105","author":"Sandlers","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108581_bb0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.14336\/AD.2015.0823","article-title":"Brain lipotoxicity of Phytanic acid and very long-chain fatty acids. Harmful cellular\/mitochondrial activities in Refsum disease and X-linked Adrenoleukodystrophy","volume":"7","author":"Sch\u00f6nfeld","year":"2016","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108581_bb0190","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells8101261","article-title":"The S100A4 transcriptional inhibitor Niclosamide reduces pro-inflammatory and migratory phenotypes of microglia: implications for amyotrophic lateral sclerosis","volume":"8","author":"Serrano","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ymgme.2024.108581_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJHTS.S10547","article-title":"High content screening for nonclassical peroxisome proliferators","author":"Sexton","year":"2010","journal-title":"Intern. J. High Throughput Screen."},{"key":"10.1016\/j.ymgme.2024.108581_bb0200","series-title":"GeneReviews\u00ae","article-title":"Zellweger Spectrum Disorder","author":"Steinberg","year":"1993"},{"key":"10.1016\/j.ymgme.2024.108581_bb0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biochi.2022.07.008","article-title":"Serum fatty acid profiling in patients with SDHx mutations: new advances on cellular metabolism in SDH deficiency","volume":"201","author":"Vamecq","year":"2022","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108581_bb0210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2006.08.010","article-title":"Peroxisomal disorders: The single peroxisomal enzyme deficiencies","volume":"1763","author":"Wanders","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108581_bb0215","first-page":"272","article-title":"Peroxisomes, lipid metabolism and lipotoxicity","volume":"1801","author":"Wanders","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108581_bb0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1152\/physrev.00051.2021","article-title":"The physiological functions of human peroxisomes","volume":"103","author":"Wanders","year":"2023","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108581_bb0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2024.108581_bib226","doi-asserted-by":"crossref","unstructured":"Choi, H.-I. et al. (2021) \u2018Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs\u2019, Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1179, p. 122862. Available at: https:\/\/doi.org\/10.1016\/j.jchromb.2021.122862.","DOI":"10.1016\/j.jchromb.2021.122862"},{"key":"10.1016\/j.ymgme.2024.108581_bib227","doi-asserted-by":"crossref","unstructured":"Yang, M. et al. (2023) \u2018Use of physiological based pharmacokinetic modeling for cross-species prediction of pharmacokinetic and tissue distribution profiles of a novel niclosamide prodrug\u2019, Frontiers in Pharmacology, 14. Available at: https:\/\/doi.org\/10.3389\/fphar.2023.1099425.","DOI":"10.3389\/fphar.2023.1099425"},{"key":"10.1016\/j.ymgme.2024.108581_bib228","doi-asserted-by":"crossref","unstructured":"Seo, J.I., Jin, G. and Yoo, H.H. (2024) \u2018Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study\u2019, Biomedicine & Pharmacotherapy, 173, p. 116394. Available at: https:\/\/doi.org\/10.1016\/j.biopha.2024.116394.","DOI":"10.1016\/j.biopha.2024.116394"},{"key":"10.1016\/j.ymgme.2024.108581_bib229","doi-asserted-by":"crossref","unstructured":"Apolloni, S. and D\u2019Ambrosi, N. (2023) \u2018Repurposing niclosamide for the treatment of neurological disorders\u2019, Neural Regeneration Research, 18(12), pp. 2705\u20132706. Available at: https:\/\/doi.org\/10.4103\/1673-5374.373705.","DOI":"10.4103\/1673-5374.373705"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:17:29Z","timestamp":1730877449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1096719224004657"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108581","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108581"}}